Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1991
06/04/1991US5021441 Organic compounds and their pharmaceutical use
06/04/1991US5021419 Novel pyrazinoxide compound of NF-1616-904 and a pharmaceutical composition containing the same
06/04/1991CA1284651C Pharmaceutical compositions containing 5-phenyl-1, 3- dioxoalkenyl compounds
06/02/1991CA2031233A1 Megakaryocyte production
05/1991
05/30/1991WO1991007495A1 A mammalian cytokine, il-11
05/30/1991WO1991007178A1 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
05/30/1991WO1991007177A1 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
05/29/1991WO1991007966A1 Immunosuppressant and process for preparing the same
05/29/1991EP0429366A1 Isoindolone derivatives, their preparation and pharmaceutical compositions containing them
05/29/1991EP0429287A2 Anti-inflammatory furanone compounds
05/29/1991EP0428860A2 Substituted (quinolin-2-yl-methoxy)phenyl-carbonyl-ureas
05/29/1991DE3938971A1 Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat Leukocyte elastase and cathepsin G-blocking peptide, dna, vector, host organism and proceed to its recovery as well as pharmaceutical of preparation
05/28/1991US5019576 Anticoagulants
05/28/1991US5019573 Substituted dibenzofurans and methods of using same
05/25/1991CA2028756A1 Immunostimulating 6-aryl-5,6-dihydro-imidazo[2,1-b]thiazole derivatives
05/24/1991CA2030633A1 Pyridine-2,4- and 2,5-dicarboxamides, a process for the preparation thereof, and the use thereof
05/24/1991CA2030570A1 Isoindolone derivatives and preparation thereof
05/24/1991CA2030569A1 Isoindolone derivatives, preparation thereof and pharmaceutical compositions containing the same
05/23/1991DE4037187A1 New anti-allergic selenophene derivs. - useful in the treatment of bronchial asthma
05/22/1991EP0428485A1 Novel antiidiotypic monoclonal antibodies
05/22/1991EP0428434A2 Compounds of aromatic amines and their enantiomers, process for their preparation and pharmaceutical compositions containing them
05/22/1991EP0428365A1 Aminomacrolides and derivatives having immunosuppressive activity
05/22/1991EP0428313A2 Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
05/22/1991EP0428268A2 Pharmaceutical phenylpyridone derivatives
05/22/1991EP0427850A1 Anti-ergotypic t cells for the treatment or prevention of autoimmune diseases and methods of use thereof
05/22/1991EP0427768A1 Polypeptide pertussis toxin vaccine
05/22/1991EP0427765A1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs
05/22/1991CN1051564A Polysaccharides, anti-coagulant and anticomplement obtained from untreated fucanes of alga, and process of preparation thereof
05/22/1991CN1051554A Indenoindole compounds ii
05/22/1991CN1051503A Treatment of conditions and disease
05/21/1991US5017703 Antiallergens, antiinflammatory
05/21/1991US5017588 Anticoagulants
05/21/1991CA2027863A1 Anti-inflammatory furanone compounds
05/21/1991CA1284336C Amido substituted naphthalenes and intermediates thereof
05/16/1991WO1991006321A1 Use of honey as vaccine
05/16/1991WO1991006319A1 Methods and compositions for promoting immunopotentiation
05/16/1991CA2071478A1 Methods and compositions for promoting immunopotentiation
05/15/1991EP0427680A1 Heteroatoms-containing tricyclic compounds
05/15/1991CN1051393A Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
05/15/1991CN1051354A Substituted cycloalano(b)dihydroindole-and-indolesulphonamides
05/15/1991CA2029965A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof
05/15/1991CA2029714A1 Antiidiotypic monoclonal antibodies
05/14/1991WO1991007401A1 3-substituted-1-(aryl or arylalkyl)-2(1h)-quinolinones
05/14/1991US5015661 Chromanes and their pharmaceutical compositions and methods
05/14/1991CA2068514A1 3-substituted-1-(aryl or arylalkyl)-2(1h)-quinolinones
05/14/1991CA2029860A1 Aminomacrolides and derivatives having immuno-suppressive activity
05/14/1991CA1284149C Substituted quinoxalinediones and quinolinediones
05/08/1991EP0426458A2 Human monocyte growth factor
05/08/1991EP0425906A2 Substituted cycloalkano[b]dihydroindol- and -indolsulfonamides
05/08/1991EP0425536A1 Nonglycosylated human interleukin-3 compositions
05/08/1991CN1051199A Modified biological material
05/07/1991US5013756 Catechol derivatives, a process of preparation thereof, and therapeutical compositions containing the same
05/07/1991US5013736 5-lipoxygenase inhibitors, smooth muscle relaxants
05/07/1991US5013724 Process for the sulfation of glycosaminoglycans, the sulfated glycosaminoglycans and their biological applications
05/07/1991US5013723 New thymopentin retro-inverso analogs and fragments thereof, a process of preparation of the new compounds and the intermediates obtained therein
05/07/1991US5013719 Administering cyclosporin A and alpha-difluoromethylornithine
05/07/1991CA2029275A1 Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
05/07/1991CA1283917C Amino acid derivatives having anti-tumor activity and compositions containing them
05/07/1991CA1283859C Penicillamine for treating immune damaging illnesses
05/03/1991WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier
05/03/1991CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof
05/02/1991WO1991005855A1 Modified biological material
05/02/1991WO1991005795A1 Stem cell factor
05/02/1991WO1991005560A1 PROTECTION FROM SHOCK SUBSEQUENT TO INJURY BY DOUBLE-STRANDED RNAs
05/02/1991WO1991005559A1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
05/02/1991EP0425362A2 Furosemide salts, process for their preparation, their use as medicines and pharmaceutical compositions containing them
05/02/1991EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use
05/02/1991EP0425109A2 3-Substituted-2-oxindole derivatives as inhibitors of interleukin-1 biosynthesis
05/02/1991EP0424848A2 Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments
05/02/1991EP0424722A2 Substituted (quinolin-2-yl-methoxy)phenyl-thioureas
05/02/1991EP0424437A1 Recombinant mycobacterial expression vehicles and uses therefor
05/02/1991CA2067235A1 Modified biological material
05/01/1991WO1991006863A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
05/01/1991CA2069313A1 Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
05/01/1991CA2028621A1 Antithrombotic substituted cycloalkano[b]dihydroindole- and -indole-sulphonamides
04/1991
04/30/1991US5011847 2,5-diaryl tetrahydrofurans and analogs thereof as PAF antagonists
04/30/1991US5011844 Substituted 4-azatricyclo(22.3.1.04,9)octacos-18-ene derivatives, their preparation and pharmaceutical compositions containing them
04/30/1991US5011842 2-(heterocyclylalkyl)imidazopyridines for treating allergic diseases
04/30/1991US5011839 3(2H)pyridazinones for antagonistic agent against srs-a
04/30/1991US5011838 Antiallergens, antihistamines
04/30/1991US5011835 Substituted triazolopyridazines, pharmaceutical compositions and use
04/30/1991US5011828 Immunostimulating guanine derivatives, compositions and methods
04/30/1991US5011684 Administering monoclonal antibody to interleukin receptor
04/28/1991WO1991006539A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006538A1 Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006537A2 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991WO1991006320A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2071502A1 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
04/28/1991CA2070422A1 Substituted indole-, indene-, pyranoindole and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2067138A1 Substituted benzoylbenzene-, biphenyl-and 2-oxazole-alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase
04/28/1991CA2067135A1 2-anilino phenylacetic acid derivatives as inhibitors of pla2 and lipoxygenase
04/26/1991CA2028314A1 Substituted (quinolin-2-yl-methoxy)phenyl-carbonylureas
04/25/1991CA2028326A1 Furosemide salts, process for the preparation thereof, application as medicaments and pharmaceutical compositions containing them
04/25/1991CA2028285A1 Aminopyridinylaminophenols and related compounds, a process and intermediates for their preparation and their use as medicaments
04/24/1991WO1991005799A1 Polypeptide inhibitors of gamma interferon
04/24/1991EP0424349A1 Synthesis of 1,4-dideoxy-1,4-imino-D-mannitol
04/24/1991EP0423980A1 Stem cell factor
04/24/1991EP0423618A1 Inosine/guanosine derivatives as immunosuppressive agents
04/24/1991EP0423221A1 Immunosuppressive agents.
04/24/1991EP0423193A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human